首页> 美国政府科技报告 >Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High Risk Castrate, Biochemically Relapsed Prostate Cancer.

【24h】

Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High Risk Castrate, Biochemically Relapsed Prostate Cancer.

机译：177Lu放射性标记的抗psma单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Tagawa, S. T.;
展开▼
作者单位

展开▼
年度 2017
页码 1-131
总页数 131
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 ( 177 177 Lu‐J591) for metastatic castration‐resistant prostate cancer [J] . Tagawa Scott T., Vallabhajosula Shankar, Christos Paul J., Cancer: A Journal of the American Cancer Society . 2019,第15期

机译：第1/2类研究分级剂量含水液-177-标记的抗前列腺特异性膜抗原单克隆抗体J591（177 177 Lu-J591）用于转移性阉割的前列腺癌
2. Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. [J] . Milowsky MI, Nanus DM, Kostakoglu L, Journal of Clinical Oncology . 2004,第13期

机译：钇90标记的抗前列腺特异性膜抗原单克隆抗体J591用于雄激素非依赖性前列腺癌的I期试验。
3. Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer [J] . TagawaS.T., MilowskyM.I., MorrisM., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第18期

机译：lut 177标记的抗前列腺特异性膜抗原单克隆抗体J591在转移性去势抵抗性前列腺癌中的II期研究
4. ~(177)Lu-DOTA-J591 MONOCLONAL ANTIBODY: CHEMISTRY, TOXICITY, DOSIMETRY AND CLINICAL EFFICACY: RIT OF PROSTATE CANCER USING ~(177)LU-J591 ANTI-PSMA ANTIBODY [C] . S.J. GOLDSMITH, S. VALLABHAJOSULA, M.I. MILOWSKY, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：〜（177）Lu-DOTA-J591单克隆抗体：化学，毒性，剂量和临床疗效：使用〜（177）LU-J591抗-PSMA抗体的前列腺癌
5. A Comparison Between Stabilization Exercises and Stabilization Exercises Supplemented with Neuromuscular Electrical Stimulation in Patients with Chronic Low Back Pain: A Phase I Randomized Controlled Trial [D] . Alrwaily, Muhammad. 2017

机译：慢性腰背痛患者稳定运动与稳定运动加神经肌肉电刺激的比较：I期随机对照试验
6. Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (177Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer [O] . Muhammad Junaid Niaz, Jaspreet S. Batra, Ryan D. Walsh, 2020

机译：ute标记的抗前列腺特异性膜抗原单克隆抗体J591（177Lu-J591）超分割剂量用于转移性去势抵抗性前列腺癌的初步研究
7. Phase 1/2 study of fractionated dose lutetium‐177–labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 ( 177 Lu‐J591) for metastatic castration‐resistant prostate cancer [O] . Scott T. Tagawa, Shankar Vallabhajosula, Paul J. Christos, 2019

机译：第1/2期分级剂量抑制-177标记的抗前列腺特异性膜抗原单克隆抗体J591（177 Lu-J591）用于转移性阉割的前列腺癌
8. Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High-Risk Castrate, Biochemically Relapsed Prostate Cancer. [R] . Tagawa, S. T. 2016

机译：177Lu放射性标记的抗psma单克隆抗体J591在高风险阉割，生物化学复发的前列腺癌患者中的随机2期试验。

Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients With High Risk Castrate, Biochemically Relapsed Prostate Cancer.

著录项

相似文献

相关主题

期刊订阅